LatestJuanmita López De Jesús Returns as Main Event Fighter at Roger Mendoza Coliseum in Caguas
Cannabis

Cancer Patients in Southern Ukraine Access Medical Cannabis Through Local Pharmacy

Redacción
Cancer Patients in Southern Ukraine Access Medical Cannabis Through Local Pharmacy
CancerChronic Pain
Summary

A pharmacy in Mykolaiv, southern Ukraine, is now producing cannabis-based medications for cancer patients available through electronic prescriptions. These medications aim to alleviate cancer-related pain and other debilitating symptoms associated with the disease and its treatments. This local pharmaceutical initiative represents a significant expansion of Ukraine's medical cannabis program, which began dispensing treatments in other cities in June. The availability of cannabis therapeutics provides cancer patients with an additional evidence-based option for symptom management and improved quality of life during treatment.

Originally published on

Revista Cáñamo

By Redacción

Read full article(opens in new tab)

Fetched: October 15, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
Uganda Strengthens Medical Cannabis Industry with Cooperative Framework
Cannabis

Uganda Strengthens Medical Cannabis Industry with Cooperative Framework

Uganda has established a cooperative organization to unite authorized medical cannabis and hemp producers, marking a significant step in regulating its emerging medicinal cannabis sector. The cooperative aims to improve product traceability, facilitate market access, and coordinate operations across the growing industry. This regulatory development strengthens quality control and supply chain transparency for medical cannabis products. The initiative reflects Uganda's commitment to establishing a structured framework as the sector expands within the country's agricultural economy. Such organizational measures are crucial for ensuring consistent product standards and building international confidence in medicinal cannabis sourcing.

2 hours ago
Revista Cáñamo
Puerto Rico Faces $53 Million Revenue Loss If Medical Cannabis Access Is Restricted
Cannabis
Chronic PainEpilepsy

Puerto Rico Faces $53 Million Revenue Loss If Medical Cannabis Access Is Restricted

Puerto Rico's Legislative Assembly Budget Office has calculated that restricting medical cannabis access could result in annual revenue losses of up to $53 million under the most severe scenario. The projection assumes a substantial reduction in eligible program participants, reflecting the current program's significant contribution to the territory's tax revenue. This fiscal analysis highlights the economic stakes as policymakers weigh potential regulatory changes against cannabis's role in providing therapeutic options for patients with chronic conditions including chronic pain, epilepsy, and multiple sclerosis. The findings underscore the tension between public health policy considerations and fiscal sustainability in Puerto Rico's medical cannabis framework.

3 hours ago
Revista Cáñamo
Cannabis Photosynthesis: Optimizing Light Intensity for Maximum Cultivation Yield
Cannabis

Cannabis Photosynthesis: Optimizing Light Intensity for Maximum Cultivation Yield

Understanding how cannabis responds to high light intensities is crucial for maximizing modern cultivation systems. This article examines photosynthetic processes, light saturation points, and evidence-based strategies to prevent heat stress and light-induced damage in medical cannabis production. Proper light optimization directly impacts cannabinoid and terpene profiles, affecting therapeutic efficacy for patients. Knowledge of saturation thresholds helps cultivators avoid counterproductive conditions that reduce yield and potency. For medical users in Puerto Rico, optimized cultivation practices ensure consistent, high-quality cannabis products with reliable therapeutic benefits.

4 hours ago
Soft Secrets (Español)
Study: Cannabis is the Most Popular Mind-Altering Substance Used While Hiking
Cannabis

Study: Cannabis is the Most Popular Mind-Altering Substance Used While Hiking

A recent study from Climbing Kilimanjaro reveals that over one-third of hikers (35%) have consumed cannabis while hiking, making it the most popular mind-altering substance on trails. The research also found that approximately 15% of hikers have used psilocybin, identifying it as the most popular psychedelic substance among outdoor recreationalists. This data highlights emerging patterns in recreational substance use during outdoor activities and raises important safety considerations for trail users and park managers. Understanding these prevalence rates is relevant for public health professionals and healthcare providers counseling patients about substance use risks in physically demanding environments.

5 hours ago
Ganjapreneur